2020 Q1 Form 10-Q Financial Statement
#000156459020025519 Filed on May 14, 2020
Income Statement
| Concept | 2020 Q1 | 2019 Q1 |
|---|---|---|
| Revenue | $290.0K | $270.0K |
| YoY Change | 7.41% | -61.43% |
| Cost Of Revenue | $78.00K | $96.00K |
| YoY Change | -18.75% | -34.69% |
| Gross Profit | $216.0K | $174.0K |
| YoY Change | 24.14% | -68.65% |
| Gross Profit Margin | 74.48% | 64.44% |
| Selling, General & Admin | $2.316M | $2.549M |
| YoY Change | -9.14% | 7.73% |
| % of Gross Profit | 1072.22% | 1464.94% |
| Research & Development | $2.974M | $3.300M |
| YoY Change | -9.88% | -42.02% |
| % of Gross Profit | 1376.85% | 1896.55% |
| Depreciation & Amortization | $50.00K | $65.00K |
| YoY Change | -23.08% | -45.83% |
| % of Gross Profit | 23.15% | 37.36% |
| Operating Expenses | $5.290M | $2.549M |
| YoY Change | 107.53% | -68.37% |
| Operating Profit | -$5.074M | -$2.375M |
| YoY Change | 113.64% | -68.35% |
| Interest Expense | -$56.00K | -$2.229M |
| YoY Change | -97.49% | 111350.0% |
| % of Operating Profit | ||
| Other Income/Expense, Net | $80.00K | $2.000K |
| YoY Change | 3900.0% | -140.0% |
| Pretax Income | -$7.860M | -$7.890M |
| YoY Change | -0.38% | -209.74% |
| Income Tax | ||
| % Of Pretax Income | ||
| Net Earnings | -$7.861M | -$7.894M |
| YoY Change | -0.42% | -209.87% |
| Net Earnings / Revenue | -2710.69% | -2923.7% |
| Basic Earnings Per Share | -$108.10 | -$75.11 |
| Diluted Earnings Per Share | -$112.3M | -$0.11 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 72.77K | 73.56M |
| Diluted Shares Outstanding | 72.74K | 105.1K |
Balance Sheet
| Concept | 2020 Q1 | 2019 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $4.540M | $260.0K |
| YoY Change | 1646.15% | -87.19% |
| Cash & Equivalents | $4.721M | $1.326M |
| Short-Term Investments | ||
| Other Short-Term Assets | $2.820M | $2.060M |
| YoY Change | 36.89% | 27.95% |
| Inventory | $790.0K | $780.0K |
| Prepaid Expenses | ||
| Receivables | $70.00K | $60.00K |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $8.220M | $3.166M |
| YoY Change | 159.63% | -39.46% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $1.560M | $3.000M |
| YoY Change | -48.0% | 152.1% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | ||
| YoY Change | ||
| Total Long-Term Assets | $1.560M | $2.994M |
| YoY Change | -47.9% | 151.6% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $8.220M | $3.166M |
| Total Long-Term Assets | $1.560M | $2.994M |
| Total Assets | $9.780M | $6.160M |
| YoY Change | 58.77% | -4.05% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $5.000M | $10.27M |
| YoY Change | -51.31% | 124.24% |
| Accrued Expenses | $8.050M | $9.380M |
| YoY Change | -14.18% | 388.54% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $5.390M |
| YoY Change | -100.0% | |
| Long-Term Debt Due | $370.0K | |
| YoY Change | ||
| Total Short-Term Liabilities | $13.04M | $25.44M |
| YoY Change | -48.74% | 107.25% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $2.000M | $0.00 |
| YoY Change | ||
| Other Long-Term Liabilities | $2.740M | $166.0K |
| YoY Change | 1550.6% | -51.88% |
| Total Long-Term Liabilities | $4.740M | $166.0K |
| YoY Change | 2755.42% | -51.88% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $13.04M | $25.44M |
| Total Long-Term Liabilities | $4.740M | $166.0K |
| Total Liabilities | $17.78M | $29.94M |
| YoY Change | -40.62% | 137.25% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$351.9M | |
| YoY Change | 10.8% | |
| Common Stock | $144.0K | |
| YoY Change | 1500.0% | |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | -$8.005M | -$23.78M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $9.780M | $6.160M |
| YoY Change | 58.77% | -4.02% |
Cashflow Statement
| Concept | 2020 Q1 | 2019 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$7.861M | -$7.894M |
| YoY Change | -0.42% | -209.87% |
| Depreciation, Depletion And Amortization | $50.00K | $65.00K |
| YoY Change | -23.08% | -45.83% |
| Cash From Operating Activities | -$5.229M | -$2.770M |
| YoY Change | 88.77% | -57.01% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $180.0K | $2.000K |
| YoY Change | 8900.0% | -66.67% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | ||
| YoY Change | ||
| Cash From Investing Activities | -$180.0K | -$2.000K |
| YoY Change | 8900.0% | -66.67% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | -117.0K | 550.0K |
| YoY Change | -121.27% | -87.07% |
| NET CHANGE | ||
| Cash From Operating Activities | -5.229M | -2.770M |
| Cash From Investing Activities | -180.0K | -2.000K |
| Cash From Financing Activities | -117.0K | 550.0K |
| Net Change In Cash | -5.462M | -2.252M |
| YoY Change | 142.54% | 1.99% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$5.229M | -$2.770M |
| Capital Expenditures | $180.0K | $2.000K |
| Free Cash Flow | -$5.409M | -$2.772M |
| YoY Change | 95.13% | -57.02% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2019Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
105084 | |
| CY2019Q4 | us-gaap |
Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
|
1:700 | |
| CY2019Q4 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.00142 | |
| CY2020Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
25000 | |
| CY2020Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
30000 | |
| CY2020Q1 | dcth |
Adjustment To Additional Paid In Capital Registration Of Preferred Stock And Related Warrants
AdjustmentToAdditionalPaidInCapitalRegistrationOfPreferredStockAndRelatedWarrants
|
-106000 | |
| CY2020Q1 | dcth |
Adjustments To Additional Paid In Capital Fair Value Of Warrants Reclassified From Liability To Equity
AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsReclassifiedFromLiabilityToEquity
|
-6199000 | |
| CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
65000 | |
| CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-14939000 | |
| CY2019Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
54000 | |
| CY2019Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
4000 | |
| CY2019Q1 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
150000 | |
| CY2019Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
|
-1160000 | |
| CY2020Q1 | dcth |
Amortization Of Right Of Use Assets
AmortizationOfRightOfUseAssets
|
172000 | |
| CY2019Q1 | dcth |
Amortization Of Right Of Use Assets
AmortizationOfRightOfUseAssets
|
0 | |
| CY2020Q1 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
40000 | |
| CY2019Q1 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
51000 | |
| CY2019Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
96000 | |
| CY2020Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-56000 | |
| CY2019Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-2229000 | |
| CY2020Q1 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
101000 | |
| CY2019Q1 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
2000 | |
| CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7861000 | |
| CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7893000 | |
| CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
65000 | |
| CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
57000 | |
| CY2020Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-7796000 | |
| CY2019Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-7836000 | |
| CY2020Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-108.07 | |
| CY2019Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-75.11 | |
| CY2020Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
72740 | |
| CY2020Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2316000 | |
| CY2020Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
78000 | |
| CY2020Q1 | us-gaap |
Gross Profit
GrossProfit
|
216000 | |
| CY2019Q1 | us-gaap |
Gross Profit
GrossProfit
|
174000 | |
| CY2019Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2549000 | |
| CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
7000 | |
| CY2019Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-23777000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-188000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-120000 | |
| CY2020Q1 | dcth |
Increase Decrease In Principal Payments On Operating Leases
IncreaseDecreaseInPrincipalPaymentsOnOperatingLeases
|
-161000 | |
| CY2019Q1 | dcth |
Increase Decrease In Principal Payments On Operating Leases
IncreaseDecreaseInPrincipalPaymentsOnOperatingLeases
|
0 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
0 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-462000 | |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-5229000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2770000 | |
| CY2020Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
180000 | |
| CY2019Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2000 | |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-180000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2000 | |
| CY2020Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
11000 | |
| CY2019Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
0 | |
| CY2020Q1 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
0 | |
| CY2019Q1 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
400000 | |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-117000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
550000 | |
| CY2020Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
64000 | |
| CY2019Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-30000 | |
| CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-5462000 | |
| CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-2252000 | |
| CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
4721000 | |
| CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
1326000 | |
| CY2020Q1 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
448000 | |
| CY2020Q1 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
342000 | |
| CY2020Q1 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
423000 | |
| CY2020Q1 | dcth |
Letters Of Credit Restricted Cash
LettersOfCreditRestrictedCash
|
131000 | |
| CY2019Q4 | dcth |
Letters Of Credit Restricted Cash
LettersOfCreditRestrictedCash
|
131000 | |
| CY2020Q1 | dcth |
Security For Credit Cards Restricted Cash
SecurityForCreditCardsRestrictedCash
|
50000 | |
| CY2019Q4 | dcth |
Security For Credit Cards Restricted Cash
SecurityForCreditCardsRestrictedCash
|
50000 | |
| CY2019Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
375000 | |
| CY2019Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
279000 | |
| CY2020Q1 | dcth |
Prepaid Clinical Trial Expenses Current
PrepaidClinicalTrialExpensesCurrent
|
1497000 | |
| CY2019Q4 | dcth |
Prepaid Clinical Trial Expenses Current
PrepaidClinicalTrialExpensesCurrent
|
725000 | |
| CY2019Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
589000 | |
| CY2020Q1 | dcth |
Prepaid Professional Service Fees
PrepaidProfessionalServiceFees
|
518000 | |
| CY2019Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
263000 | |
| CY2020Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
170000 | |
| CY2020Q1 | dcth |
Financing Lease Cost
FinancingLeaseCost
|
12000 | |
| CY2020Q1 | us-gaap |
Sublease Income
SubleaseIncome
|
43000 | |
| CY2019Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
445000 | |
| CY2019Q4 | dcth |
Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
|
0.05 | |
| CY2020Q1 | us-gaap |
Lease Cost
LeaseCost
|
139000 | |
| CY2020Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
170000 | |
| CY2020Q1 | us-gaap |
Proceeds From Lease Payments
ProceedsFromLeasePayments
|
43000 | |
| CY2020Q1 | dcth |
Finance Lease Principal Payment On Liability
FinanceLeasePrincipalPaymentOnLiability
|
11000 | |
| CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
523000 | |
| CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
198000 | |
| CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
721000 | |
| CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
32000 | |
| CY2020Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
689000 | |
| CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1640 | |
| CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1640 | |
| CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1640 | |
| CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
196.70 | |
| CY2019Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
5246000 | |
| CY2019Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
4511000 | |
| CY2020Q1 | dcth |
Property Plant And Equipment Depreciation Expense
PropertyPlantAndEquipmentDepreciationExpense
|
100000 | |
| CY2019Q1 | dcth |
Property Plant And Equipment Depreciation Expense
PropertyPlantAndEquipmentDepreciationExpense
|
100000 | |
| CY2020Q1 | dcth |
Accrued Clinical Expenses Current
AccruedClinicalExpensesCurrent
|
2580000 | |
| CY2019Q4 | dcth |
Accrued Clinical Expenses Current
AccruedClinicalExpensesCurrent
|
2497000 | |
| CY2019Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
3525000 | |
| CY2020Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
550000 | |
| CY2020Q1 | dcth |
Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
|
0.05 | |
| CY2020Q1 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P12M | |
| CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
196.70 | |
| CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
196.70 | |
| CY2019 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P9Y1M6D | |
| CY2020Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y10M24D | |
| CY2020Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P8Y10M24D | |
| CY2020Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
0 | |
| CY2020Q1 | dcth |
Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
|
54000 | |
| CY2019Q1 | dcth |
Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
|
54000 | |
| CY2020Q1 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
|
2717 | |
| CY2019Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
1826608 | |
| CY2020Q1 | dcth |
Class Of Warrant Or Right Expired In Period
ClassOfWarrantOrRightExpiredInPeriod
|
9 | |
| CY2020Q1 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
1826599 | |
| CY2019Q4 | dcth |
Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
|
23.04 | |
| CY2020Q1 | dcth |
Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
|
23.04 | |
| CY2019 | dcth |
Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
|
P5Y | |
| CY2020Q1 | dcth |
Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
|
P4Y8M12D | |
| CY2019Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
3368000 | |
| CY2020Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
|
2832000 | |
| CY2020Q1 | dcth |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Fair Value Of Warrants Reclassified From Liability To Equity
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFairValueOfWarrantsReclassifiedFromLiabilityToEquity
|
6200000 | |
| CY2020Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3690825 | |
| CY2019Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5827163 |
